Literature DB >> 20046124

Muscle in defense.

Adam Lightfoot1, Anne McArdle, Richard D Griffiths.   

Abstract

The physical inactivity of the critically ill patient is an abnormal state that compromises muscle function to an extent that the immobile skeletal muscle may not simply be a bystander in the disease process.Skeletal muscle seems to maintain a system of defense against inflammation through heat shock proteins and the production of myokines. It contributes in a bidirectional role in systemic inflammatory signaling and the modulation of the inflammatory response. Skeletal muscle is a major contributor to whole-body glucose and protein metabolism, exemplified by its role in nutrient provision for the immune system and other rapidly dividing tissues through glutamine production.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20046124     DOI: 10.1097/CCM.0b013e3181b6f8a5

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  18 in total

1.  Serum creatinine level, a surrogate of muscle mass, predicts mortality in critically ill patients.

Authors:  Charat Thongprayoon; Wisit Cheungpasitporn; Kianoush Kashani
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

2.  Skeletal muscle predicts ventilator-free days, ICU-free days, and mortality in elderly ICU patients.

Authors:  Lesley L Moisey; Marina Mourtzakis; Bryan A Cotton; Tahira Premji; Daren K Heyland; Charles E Wade; Eileen Bulger; Rosemary A Kozar
Journal:  Crit Care       Date:  2013-09-19       Impact factor: 9.097

3.  Close to recommended caloric and protein intake by enteral nutrition is associated with better clinical outcome of critically ill septic patients: secondary analysis of a large international nutrition database.

Authors:  Gunnar Elke; Miao Wang; Norbert Weiler; Andrew G Day; Daren K Heyland
Journal:  Crit Care       Date:  2014-02-10       Impact factor: 9.097

4.  Validation of ultrasonographic muscle thickness measurements as compared to the gold standard of computed tomography in dogs.

Authors:  Lindsey E Bullen; Maria G Evola; Emily H Griffith; Gabriela S Seiler; Korinn E Saker
Journal:  PeerJ       Date:  2017-01-25       Impact factor: 2.984

5.  Inter- and intra-observer variability of ultrasonographic arm muscle thickness measurement by critical care physicians.

Authors:  V Hadda; R Kumar; A Dhungana; M A Khan; K Madan; G C Khilnani
Journal:  J Postgrad Med       Date:  2017 Jul-Sep       Impact factor: 1.476

6.  Complex inter-relationship of body mass index, gender and serum creatinine on survival: exploring the obesity paradox in melanoma patients treated with checkpoint inhibition.

Authors:  Girish S Naik; Sushrut S Waikar; Alistair E W Johnson; Elizabeth I Buchbinder; Rizwan Haq; F Stephen Hodi; Jonathan D Schoenfeld; Patrick A Ott
Journal:  J Immunother Cancer       Date:  2019-03-29       Impact factor: 13.751

Review 7.  Could Exogenous Insulin Ameliorate the Metabolic Dysfunction Induced by Glucocorticoids and COVID-19?

Authors:  Martin Brunel Whyte; Prashanth R J Vas; Anne M Umpleby
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-18       Impact factor: 5.555

8.  Skeletal muscle heat shock protein 70: diverse functions and therapeutic potential for wasting disorders.

Authors:  Sarah M Senf
Journal:  Front Physiol       Date:  2013-11-11       Impact factor: 4.566

9.  Predictive factors of in-hospital mortality in ventilated intensive care unit: A prospective cohort study.

Authors:  Chiu-Hua Wang; Horng-Chyuan Lin; Yue-Cune Chang; Suh-Hwa Maa; Jong-Shyan Wang; Woung-Ru Tang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

10.  miR-424-5p reduces ribosomal RNA and protein synthesis in muscle wasting.

Authors:  Martin Connolly; Richard Paul; Roser Farre-Garros; Samantha A Natanek; Susannah Bloch; Jen Lee; Jose P Lorenzo; Harnish Patel; Cyrus Cooper; Avan A Sayer; Stephen J Wort; Mark Griffiths; Michael I Polkey; Paul R Kemp
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-12-07       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.